Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Disease model: Parkinson's disease.

Shun Shimohama¹, Hideyuki Sawada, Yoshihisa Kitamura

¹Department of Neurology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyoku, 606-8507 Kyoto, Japan. i53367@sakura.kudpc.kyoto-u.ac.jp

Trends in Molecular Medicine

|August 21, 2003

Summary

This review covers Parkinson's disease (PD) models, including in vivo and in vitro approaches. Understanding these models is crucial for developing new therapies for this progressive neurodegenerative disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identification of daurioxoisoporphine D and moringamine I as blood-brain barrier-permeable natural inhibitors of amyloid-β aggregation and neuronal toxicity.

Bioorganic & medicinal chemistry·2026

Same author

Hallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson's disease.

BMJ neurology open·2026

Same author

Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome.

Immunology·2025

Same author

Stimulation of α7 Nicotinic Acetylcholine Receptors by PNU282987 Demonstrates Efferocytosis-Like Activation and Neuroprotection in Human Models of Microglia and Cholinergic Neurons under the Pathophysiological Conditions of Alzheimer's Disease.

Biological & pharmaceutical bulletin·2025

Same author

3D observational analysis of convection around and inside a self-propelled droplet.

RSC advances·2025

Same author

Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes.

Frontiers in immunology·2025

Area of Science:

Neuroscience
Pathology
Pharmacology

Background:

Parkinson's disease (PD) involves the degeneration of dopaminergic neurons.
Key pathological hallmarks include Lewy bodies with alpha-synuclein and ubiquitin.
Both genetic and environmental factors contribute to PD pathogenesis.

Purpose of the Study:

To review and discuss the utility of existing in vivo and in vitro models for Parkinson's disease.
To provide insights into understanding PD pathophysiology.
To aid in the development of novel therapeutic strategies for PD.

Main Methods:

Literature review of in vivo models (e.g., animal models).
Literature review of in vitro models (e.g., cell cultures).
Analysis of the strengths and limitations of each model type.

Related Experiment Videos

Main Results:

Various animal models mimic aspects of PD neurodegeneration.
Cell-based models allow investigation of specific molecular mechanisms.
Each model offers unique advantages for studying PD.

Conclusions:

Relevant disease models are essential for advancing Parkinson's disease research.
In vivo and in vitro models provide valuable tools for understanding PD.
Further development and application of these models can accelerate therapeutic discovery.